1. Intellectual Property and the Politics of Public Good in COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO
- Author
-
Fischer, Sara E, Vitale, Lucia, Agutu, Akinyi Lisa, and Kavanagh, Matthew M
- Subjects
Policy and Administration ,Political Science ,Human Society ,Infectious Diseases ,Emerging Infectious Diseases ,Peace ,Justice and Strong Institutions ,Humans ,International Cooperation ,Negotiating ,COVID-19 ,Commerce ,Politics ,Intellectual Property ,Vaccines ,WTO ,framing ,TRIPS waiver ,pandemic ,Public Health and Health Services ,Law ,Health Policy & Services ,Policy and administration ,Political science - Abstract
ContextTo facilitate the manufacturing of COVID-19 medical products, in October 2020 India and South Africa proposed a waiver of certain intellectual property (IP) provisions of a World Trade Organization (WTO) agreement. After nearly two years, a narrow waiver agreement that did little for vaccine access passed the ministerial despite the pandemic's impact on global trade, which the WTO is mandated to safeguard.MethodsThe authors conducted a content analysis of WTO legal texts, key-actor statements, media reporting, and the WTO's procedural framework to explore legal, institutional, and ideational explanations for the delay.FindingsIP waivers are neither legally complex nor unprecedented within WTO law, yet these waiver negotiations exceeded their mandated 90-day negotiation period by approximately 18 months. Waiver opponents and supporters engaged in escalating strategic framing that justified and eventually secured political attention at head-of-state level, sidelining other pandemic solutions. The frames deployed discouraged consensus on a meaningful waiver, which ultimately favored the status quo that opponents preferred. WTO institutional design encouraged drawn-out negotiation while limiting legitimate players in the debate to trade ministers, empowering narrow interest group politics.ConclusionsDespite global political attention, the WTO process contributed little to emergency vaccine production, suggesting a pressing need for reforms aimed at more efficient and equitable multilateral processes.
- Published
- 2024